文献速递传染病防控与疫情报告免疫规划

2016-2020年美国人际传播相关的甲型肝炎广泛暴发

Widespread Hepatitis A Outbreaks Associated with Person-to-Person Transmission - United States, 2016-2020.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2022-09-30

美国1995-2015年甲肝感染率下降约97%,但2016年起37个州暴发人际传播相关甲肝,截至2022年9月23日约44650例、27250例住院、415例死亡。CDC分析2016年8月1日至2020年12月31日33个暴发州37553例资料,有危险因素或临床结局信息者中56%报告用药、14%报告无家可归、61%住院,报告380例暴发相关死亡。2019年ACIP建议无家可归者接种甲肝疫苗并强化用药者现有接种建议。

要点

  • 2016-2020年33个暴发州37553例中,有信息者56%报告用药、14%报告无家可归、61%住院。
  • 截至2022年9月23日,37个州报告约44650例、27250例住院和415例死亡。
  • 2019年ACIP建议无家可归者接种甲肝疫苗,并强化对用药者的现有接种建议。

核心结论

  • 甲肝暴发已从污染食物相关的点源暴发转变为社区人际传播暴发,接种甲肝疫苗是预防和控制暴发最有效的手段。
  • 需要提高甲肝疫苗接种覆盖率,尤其在受严重影响人群中实施成功的非传统接种策略,以继续控制当前暴发并预防未来类似暴发。

研究设计与样本

  • CDC对2016年8月1日至2020年12月31日期间33个受暴发影响州报告的37553例暴发相关甲肝病例的临时数据进行描述性分析,描述人口学、危险因素和临床结局特征。

主要发现

  • 在具有可用危险因素或临床结局信息的病例中,56%报告用药,14%报告无家可归,61%住院。
  • 报告380例暴发相关死亡。
  • 截至2022年9月23日,37个州报告约44650例病例、27250例住院和415例死亡。
  • 受暴发影响的州数量已从37个减少到13个。

关键数值与推荐

  • 2019年免疫实践咨询委员会(ACIP)建议无家可归者接种甲肝疫苗,并强化对用药者的现有接种建议。
  • 1995-2015年期间,美国甲肝病毒感染率下降约97%。

临床怎么用

  • 接种甲肝疫苗是预防和控制甲肝暴发最有效的手段,尤其针对甲肝病毒感染风险增加的人群。
  • 需要提高甲肝疫苗接种覆盖率,特别是在受严重影响人群中实施成功的非传统接种策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hepatitis A is a vaccine-preventable disease typically acquired through fecal-oral transmission. Hepatitis A virus (HAV) infection rates in the United States declined approximately 97% during 1995-2015 after the introduction and widespread pediatric use of hepatitis A vaccines (1). Since 2016, hepatitis A outbreaks have been reported in 37 states, involving approximately 44,650 cases, 27,250 hospitalizations, and 415 deaths as of September 23, 2022 (2). A report describing early outbreaks in four states during 2017 noted that most infections occurred among persons reporting injection or noninjection drug use or experiencing homelessness; this finding signaled a shift in HAV infection epidemiology from point-source outbreaks associated with contaminated food to large community outbreaks associated with person-to-person transmission (3). CDC analyzed interim data from 33 outbreak-affected states to characterize demographic, risk factor, and clinical outcome data from 37,553 outbreak-associated hepatitis A cases reported during August 1, 2016-December 31, 2020. Among persons with available risk factor or clinical outcome information, 56% reported drug use, 14% reported experiencing homelessness, and 61% had been hospitalized; 380 outbreak-associated deaths were reported. The most effective means to prevent and control hepatitis A outbreaks is through hepatitis A vaccination, particularly for persons at increased risk for HAV infection (4). The epidemiologic shifts identified during these outbreaks led to a 2019 recommendation by the Advisory Committee on Immunization Practices (ACIP) for vaccination of persons experiencing homelessness and reinforcement of existing vaccination recommendations for persons who use drugs (4). Substantial progress in the prevention and control of hepatitis A has been made; the number of outbreak-affected states has been reduced from 37 to 13 (2). Increased hepatitis A vaccination coverage, particularly through implementation of successful, nontraditional vaccination strategies among disproportionately affected populations (5), is needed to continue progress in halting current outbreaks and preventing similar outbreaks in the future.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Foster MA, Hofmeister MG, Yin S, et al. Widespread Hepatitis A Outbreaks Associated with Person-to-Person Transmission - United States, 2016-2020. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36173747. doi:10.15585/mmwr.mm7139a1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。